NCT06967077

Brief Summary

Axial spondyloarthritis (axSpA) is an autoimmune disease that causes inflammatory arthritis of the spine, causing pain, stiffness, and mobility limitations. During flares, when symptoms worsen, people with axSpA often experience increased pain and difficulty moving, making daily activities more challenging. This study aims to explore whether virtual reality (VR) exercise can help manage pain, improve movement, and support rehabilitation for axSpA patients during flares. Participants will use a VR system to perform gentle exercises designed to encourage movement and reduce discomfort. Their spinal mobility will be measured using motion capture technology, and their experiences with VR will be assessed through questionnaires and interviews. This research will help determine whether VR can be a practical and beneficial tool for axSpA rehabilitation, potentially offering a new way to manage symptoms and improve quality of life. The findings will guide future studies on using VR in healthcare settings for people with chronic pain conditions.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Sep 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Sep 2025Dec 2027

First Submitted

Initial submission to the registry

March 26, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2027

Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

March 26, 2025

Last Update Submit

May 7, 2025

Conditions

Outcome Measures

Primary Outcomes (12)

  • 1. Change in spinal mobility

    Spinal mobility will be assessed using range of motion (ROM) measured via motion capture system.

    between baseline and one month follow up

  • Change in movement velocity

    Movement velocity of spinal flexion, extension, and rotation will be measured using a motion capture system. Peak angular velocity (degrees/second) will be recorded during standardised movement tasks and compared between baseline and one-month follow-up. Unit of Measure: Degrees/second

    Baseline to one month follow up

  • Change in kinesiophobia

    Kinesiophobia will be measured using the Tampa Scale of Kinesiophobia (TSK). The scale ranges from 17 to 68, with higher scores indicating greater fear of movement. Unit of Measure: TSK score (17-68; higher = worse)

    Baseline to one month follow up

  • Change in pain intensity

    Pain intensity will be assessed using the Visual Analogue Scale (VAS). The scale ranges from 0 to 10, with higher scores indicating greater pain. Change from baseline to follow-up will be analysed. Unit of Measure: VAS score (0-10; higher = worse)

    Baseline to one month follow up

  • Changes in Pain severity and location

    Pain severity and location will be assessed using the McGill Pain Questionnaire Short Form (MPQ-SF). The scale ranges from 0 to 78, with higher scores indicating greater pain severity. Unit of Measure: MPQ-SF score (0-78; higher = worse)

    Baseline to one month follow up

  • proprioception impairment

    Changes in JPE scores between flare and non-flare stages to determine proprioception impairments Joint Position Error (JPE) will be measured using a spine movement reposition task by asking participants to duplicate angle of movement (for example 45 degree of spine flexion) to assess spine proprioception. Higher JPE scores reflect greater proprioceptive impairment. Unit of Measure: Degrees of deviation from target position Scale Range: 0-180 degrees (theoretically depends on direction of movement); lower scores indicate better proprioception

    from baseline to one month follow up.

  • Change in spinal flexibility

    Spinal flexibility will be measured using the Bath Ankylosing Spondylitis Metrology Index (BASMI). The scale ranges from 0 to 10, with higher scores indicating worse spinal mobility. Unit of Measure: BASMI score (0-10; higher = worse)

    Baseline to one month follow up

  • Change in Disease Activity

    Improvement in disease activity assessed using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    Baseline to one month follow up

  • Change in Functional Limitation

    Improvement in functional limitation as assessed by the Bath Ankylosing Spondylitis Functional Index (BASFI) and its correlation with objective movement parameters. BASFI (0-10 scale): Higher scores indicate worse functional limitation.

    from baseline to one month follow up.

  • Usability of VR rehabilitation

    Usability will be assessed using the System Usability Scale (SUS). SUS: A 10-item scale with scores ranging from 0 to 100. Higher scores indicate better usability. Unit of Measure: SUS score (0-100)

    from baseline to one month follow up.

  • Motion Sickness Symptoms During VR Use

    motion sickness, will be assessed using the Virtual Reality Sickness Questionnaire (VRSQ). VRSQ: Includes multiple subscales measuring symptoms such as oculomotor strain and disorientation. Higher scores indicate greater motion sickness symptoms. Unit of Measure: VRSQ subscale scores

    Baseline to one month follow up

  • Acceptability of VR Rehabilitation

    Acceptability will be assessed through semi-structured interviews exploring participants' experiences, perceived benefits, barriers to use, and overall views on the intervention. Unit of Measure: Qualitative themes derived from participant interviews

    Baseline to one month follow up

Study Arms (2)

control group

NO INTERVENTION

Participants will undergo baseline assessments which includes: 1. Spinal ROM and speed of movement, using a motion capture system (mocap) 2. Questionnaires: BASFI, BASMI, BASDAI, TSK, PCS, VAS, and McGill Pain Questionnaire. 3. JPE Testing: Proprioception will be assessed using VR system by targeting specific joint positions 10 times based on each participant's full ROM.

Virtual reality group

EXPERIMENTAL

Participants will undergo baseline assessments which includes: 1. Spinal ROM and speed of movement, using a motion capture system (mocap) 2. Questionnaires: BASFI, BASMI, BASDAI, TSK, PCS, VAS, and McGill Pain Questionnaire. 3. JPE Testing: Proprioception will be assessed using VR system by targeting specific joint positions 10 times based on each participant's full ROM. additionally they will be performing the VR tennis game for 10 minutes daily during flare stage. followed by feasibility assessment including usability and acceptability assessment of the VR intervention using both questionnaires and interviews during second and third sessions.

Other: Virtual reality head set.

Interventions

Tennis game exercise using virtual reality head set

Virtual reality group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of axial spondyloarthritis (axSpA).
  • Experiencing an active flare of axSpA within the last 6 months
  • Over 18 years of age.

You may not qualify if:

  • History of major spinal surgery.
  • Pregnancy.
  • Severe vestibular disorders, visual, balance, neurological, or cardiovascular conditions that may affect mobility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Hoffman HG, Patterson DR, Carrougher GJ, Sharar SR. Effectiveness of virtual reality-based pain control with multiple treatments. Clin J Pain. 2001 Sep;17(3):229-35. doi: 10.1097/00002508-200109000-00007.

    PMID: 11587113BACKGROUND
  • Seerden SFL, Dankaerts W, Swinnen TW, Westhovens R, De Vlam K, Vanwanseele B. Axial Spondyloarthritis is associated with changes in lumbosacral loading during daily activities. Clin Biomech (Bristol). 2021 May;85:105347. doi: 10.1016/j.clinbiomech.2021.105347. Epub 2021 Apr 3.

    PMID: 33905963BACKGROUND
  • Seerden SFL, Dankaerts W, Swinnen TW, Westhovens R, De Vlam K, Vanwanseele B. Differences in multi-segmental spine kinematics between patients with different stages of axial spondyloarthritis and healthy controls. Musculoskelet Sci Pract. 2021 Jun;53:102368. doi: 10.1016/j.msksp.2021.102368. Epub 2021 Mar 19.

    PMID: 33780698BACKGROUND
  • Mouatt, B., Smith, A.E., Mellow, M.L., Parfitt, G., Smith, R.T. and Stanton, T.R., 2020. The use of virtual reality to influence motivation, affect, enjoyment, and engagement during exercise: A scoping review. Frontiers in Virtual Reality, 1, p. 564664.

    BACKGROUND
  • Ozen T, Tonga E, Polat MG, Bayraktar D, Akar S. Cervical proprioception accuracy is impaired in patients with axial spondyloarthritis. Musculoskelet Sci Pract. 2021 Feb;51:102304. doi: 10.1016/j.msksp.2020.102304. Epub 2020 Nov 16.

    PMID: 33227676BACKGROUND
  • Barnett R, Ng S, Sengupta R. Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience. Rheumatol Adv Pract. 2021 Nov 15;5(3):rkab082. doi: 10.1093/rap/rkab082. eCollection 2021.

    PMID: 34926981BACKGROUND
  • Aouad K, Gossec L. Defining and managing flares in axial spondyloarthritis. Curr Opin Rheumatol. 2022 Jul 1;34(4):195-202. doi: 10.1097/BOR.0000000000000883. Epub 2022 Jun 9.

    PMID: 35699318BACKGROUND

MeSH Terms

Conditions

Axial Spondyloarthritis

Condition Hierarchy (Ancestors)

SpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritis

Central Study Contacts

Dario Cazzola, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: This study will employ the Trials within Cohort (TwiCs), which facilitates running an RCT by recruiting one control group for biomechanical and virtual reality assessments. From this group, eligible patients will be randomly selected to join the intervention arm, which involves a VR exercise intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator (PhD student)

Study Record Dates

First Submitted

March 26, 2025

First Posted

May 13, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

December 10, 2027

Last Updated

May 13, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD), including movement analysis, pain scores, and patient-reported outcomes, will be shared exclusively with my PhD supervisors for internal review and guidance. No public access or external data requests will be permitted. Personal identifiers will be removed to maintain confidentiality

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will be made available to supervisors during the study period and up to one year after completion for internal review and analysis
Access Criteria
Access is restricted to my PhD supervisors for internal study review. No external sharing will be permitted. The data will be handled in accordance with institutional and ethical guidelines